NCT06905626View on ClinicalTrials.gov

Weight Gain Prevention in Adolescents and Young Adults

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

May 31, 2030

Study Completion Date

May 31, 2031

Conditions

Healthy Volunteers

Interventions

DRUG

Qsymia 7.5 miligrams (mg)-46 mg Extended Release Capsule

Qsymia

DRUG

Placebo

Placebo

All Listed Sponsors

lead

University of Minnesota

OTHER